X-linked lymphoproliferative syndrome.
Nelson DL, Terhorst C.
Clin Exp Immunol. 2000 Dec;122(3):291-5. doi: 10.1046/j.1365-2249.2000.01400.x.
X-linked lymphoproliferative syndrome.
Sullivan JL, Woda BA.
Immunodefic Rev. 1989;1(4):325-47.
[X-linked lymphoproliferative syndrome].
Kanegane H.
Nihon Rinsho Meneki Gakkai Kaishi. 2002 Feb;25(1):129-34.
X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE.
Br J Haematol. 2011 Jan;152(1):13-30. doi: 10.1111/j.1365-2141.2010.08442.x. Epub 2010 Nov 18.
X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.
Blackburn PR, Lin WL, Miller DA, Lorenzo-Betancor O, Edwards ES, Zimmermann MT, Farrugia LP, Freeman WD, Soto AI, Walton RL, Klee EW, Atwal PS, Abraham RS, Billadeau DD, Ross OA, Dickson DW, Meschia JF.
J Neuropathol Exp Neurol. 2019 May 1;78(5):460-466. doi: 10.1093/jnen/nlz018.
The abnormal gene in X-linked lymphoproliferative syndrome.
Sullivan JL.
Curr Opin Immunol. 1999 Aug;11(4):431-4. doi: 10.1016/S0952-7915(99)80072-7.
X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C, Latour S.
J Clin Immunol. 2015 May;35(4):331-8. doi: 10.1007/s10875-015-0141-9. Epub 2015 Mar 4.
Post-Transplantation Lymphoproliferative Disorders in Adults.
Dierickx D, Habermann TM.
N Engl J Med. 2018 Feb 8;378(6):549-562. doi: 10.1056/NEJMra1702693.
Natural killer T cells and X-linked lymphoproliferative syndrome.
Latour S.
Curr Opin Allergy Clin Immunol. 2007 Dec;7(6):510-4. doi: 10.1097/ACI.0b013e3282f1bad6.
X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T, Zhao Q, Li W, Chen X, Xue X, Chen Z, Du X, Bai X, Zhao Q, Zhou L, Tang X, Yang X, Kanegane H, Zhao X.
Eur J Pediatr. 2020 Feb;179(2):327-338. doi: 10.1007/s00431-019-03512-7. Epub 2019 Nov 21.
